Persistent Mullerian duct syndrome Authors: Ons Krimi, Nayssem Khessairi, Mohamed Ammine Bouida, Malek Bouhani, Imen Sassi, Selma Kacem, Jamel Ben Hassouna, Tarek Ben Dhiab Published: 2026 ABSTRACT AbstractPersistent Müllerian Duct Syndrome is a rare genetic disorder, consisting in the persistence of the müllerian structures in males. We report the case of a 29-year-old male patient presented with an abdominopelvic mass. Radiological examination showed a 30cm abdominopelvic mass that was biopsied, and the pathological examination concluded to a testicular seminoma. The patient underwent surgery after neoadjuvant chemotherapy, where a uterus with right adnexa were discovered.This case highlights the therapeutic challenges of persistent Müllerian duct syndrome and the importance of the early diagnosis to optimize fertility and reduce the risk of testicular degeneration.Keywords: Persistent müllerian duct syndrome, Disorders of sex development, Cryptorchidism, AMH, AMHR2 Introduction Persistent Müllerian Duct Syndrome (PMDS) is a rare congenital malformation, with less than 200 cases reported in the literature.1 This syndrome is related to a mutation of the anti-Mullerian hormone gene or of its membrane receptor.2 The mode of transmission is autosomal recessive and involves the persistence of Müllerian structures in a male phenotype and genotype patient.2 Its discovery is often incidental at a young age during surgery for cryptorchidism or testicular ectopy. We report herein the first case of a Mullerian duct persistence syndrome discovered in our institute during surgery for a testicular seminoma. This case has been reported according to the SCARE checklist.3 Case presentation A 29-year-old patient, hypertensive, married with no children, presented with an abdominal mass evolving for 3 months with a history of not quantified weight loss. Clinical examination revealed the presence of a 20 cm firm, painless abdominopelvic mass. Furthermore, secondary sexual characteristics were present, but the patient had a 5cm testicular mass on an ectopic right inguinal testicle and a left hydrocele. A thoraco-abdomino-pelvic computed tomodensitometry (CT) scan was performed and showed a heterogeneous, poorly limited and hypervascular abdominopelvic mass of 20 × 30 cm associated with peritoneal carcinosis, hepatic and pulmonary metastases (Fig. 1). Additionally, a tumor-like, 5cm right testicular mass on an ectopic inguinal testicle was noticed. The Alpha fetoprotein (AFP) rate was negative (0.78 ng/ml). However, those of lactate dehydrogenase (LDH) and beta-human chorionic gonadotropin (BHCG) were very elevated, 7843UI/L and 1999UI/mL, respectively. A CT scan-guided biopsy of the abdominal mass was performed, and the histological examination concluded to a testicular seminoma. Cross-sectional image from an abdominal CT scan showing a large abdominal-pelvic mass (black arrow) exerting a mass effect on adjacent structures. The case was subsequently discussed in a multidisciplinary consultation meeting, and in view of the therapeutic emergency, we started with neoadjuvant chemotherapy, 2 cycles of Bleomycin + cisplatin + etoposide. A good therapeutic response was observed, with improvement of the patient's general condition, a considerable decrease in LDH rates, regression of the carcinosis nodules, decrease in the size of the abdominal mass and stability of the secondary hepatic and pulmonary lesions. Surgery of the residual masses was then indicated and was performed by highly experienced surgical oncologists. During the intraoperative exploration, a left intra-abdominal ectopic testicle was found, taken by a 20 cm mass, and adhering to a uterus with right adnexa. Peritoneal carcinosis limited to the pelvis was also noticed. An R0 resection was performed with; left orchiectomy removing the seminoma (Fig. 2), hysterectomy, adnexectomy and pelvic peritonectomy removing the carcinosis (Fig. 3). The definitive pathological examination concluded to a pure left testicle seminoma invading the spermatic cord and epididymis. Intraoperative image showing the orchidectomy specimen containing the seminoma. Intraoperative image showing the specimen of hysterectomy and bilateral adnexectomy, including the pelvic peritoneum Black arrow: Adnexa Blue arrow: Fibrous remnant of the vagina Red arrow: Pelvic peritoneum White arrow: Uterus. The uterus was free of any tumor proliferation, with a cervix deprived of exo-cervical mucosa. The postoperative follow-up was simple and adjuvant chemotherapy was indicated. In addition, the patient received structured psychological support as part of his multidisciplinary postoperative management. He refused to perform karyotype and we respected his decision. Currently, he is undergoing chemotherapy, in good general condition and without signs of locoregional or distant recurrence. Discussion Persistent Müllerian Duct Syndrome (PMDS) is an uncommon sexual development disorder, first described in 1939 by Nilson et al.4 PMDS poses significant diagnostic challenges due to its rarity and the variability in clinical presentations. It is characterized by the presence of a bicornuate uterus, fallopian tubes and upper third of the vagina in normally masculinized 46,XY subjects.5 Less than 200 cases have been reported in the literature.6 The condition often goes undetected or misdiagnosed, leading to delays in appropriate management. One of the primary diagnostic challenges lies in distinguishing PMDS from other intersex conditions, such as androgen insensitivity syndrome or disorders of sexual development. Genetically, it may be caused either by the absence of the anti-Mullerian hormone (AMH) production following a mutation of its gene 19p13.3, or by a peripheral resistance to the action of this hormone due to an anomaly of its type 2 receptor (AMHR2).7 PMDS is transmitted as an autosomal recessive condition.8 During the 8th week of gestation, the fetal testicles secrete AMH by the Sertoli cells which leads to the regression of the Muller's ducts.6,8 Only the hydatid of Morgani, the prostatic utricle (rudimentary equivalent of the vagina) and the veru montanum (equivalent of the hymen) remain. At the same time, the testosterone secreted by the fetal testicles stimulates the differentiation of the male external genitalia from the Wolffian ducts.8 Subjects with PMDS will therefore have a male genotype (karyotype: 46 XY), a male phenotype with a variable clinical presentation combining cryptorchidism or testicular ectopy, inguinal hernia, or protrusion of the Mullerian structures through the inguinal ring.9,10 Clinically, three forms of presentation can be encountered11: Female form: both testicles are located intra-abdominally. Male form (most common): one testicle is inguinal or scrotal, the other is intra-abdominal (the case of our patient). Transverse testicular ectopia: one or both testicles and fallopian tubes are located in the bursa.11 The discovery of the persistence of Mullerian structures (uterus, fallopian tubes, and upper 2/3 of the vagina) is mostly incidental during surgery for cryptorchidism/testicular ectopy, hernia in a child or exceptionally in adults during surgery for a testicular tumor (as was the case in our patient). The diagnosis of PMDS can also be suspected on radiological examinations; abdominopelvic ultrasound, computed tomodensitometry scan, but especially on pelvic magnetic resonance imaging (MRI) which allows a good investigation of the pelvic structures and identification of the Mullerian structures, however, in the case of our patient the large testicular mass made the radiological diagnosis more complicated.2 The surgery may sometimes be complicated because of the close connection between the vas deferens and the lateral walls of the uterus as well as the shortness of the spermatic pedicle. Also, the removal of Müllerian organs is controversial because of two complications of PMDS: infertility and malignancy. Infertility is the most frequent complication of PMDS.12 Hysterectomy should be avoided because of the risk of testicular devascularization, especially since degeneration of Mullerian structures is exceptional13,14. The risk of malignant degeneration of the testicles increases with testicular ectopia or cryptorchidism, which lead to changes in the microenvironment of the testicular cells13. In this case orchiectomy, hysterectomy and bilateral adnexectomy are necessary13,14. All histological types can be observed, including seminoma, which is considered to have a good prognosis with a 98% cure rate and rarely develops metastases.13,14 Nevertheless, our patient presented in an advanced metastatic state. For this type of tumor, the quantification of tumor markers levels is necessary for the staging of the disease, diagnostic orientation in case of doubt about histology, follow-up, and evaluation of the therapeutic response.15 The marked elevation of LDH rates in our case reflects the metabolism and growth of the tumor and has a prognostic value. Management is essentially surgical for localized stages, an orchiectomy is considered sufficient and adjuvant treatment is not necessary, although, for advanced stages, neoadjuvant chemotherapy followed by surgery of residual masses and lymph node dissection is required.16 Psychological and emotional support is a crucial component of PMDS management. Individuals diagnosed with PMDS may face challenges related to gender identity, body image, and societal expectations. Inclusion of mental health professionals in the management team is essential to address these aspects and provide support throughout the diagnostic and treatment journey. Conclusion The persistent Müllerian duct syndrome is a rare form of male pseudo hermaphrodism distinguished by the persistence of Mullerian structures in a patient with a male genotype and phenotype with an increased risk of malignant degeneration of the testicles, which are often in an ectopic position. This case illustrates the importance of early discovery and adequate management of this syndrome from a young age to avoid infertility and incites regular follow-up in order to not dismiss any degeneration. CRediT authorship contribution statement Ons Krimi: Writing – review & editing, Writing – original draft, Investigation. Nayssem Khessairi: Investigation. Mohamed Ammine Bouida: Conceptualization. Malek Bouhani: Conceptualization. Imen Sassi: Supervision. Selma Kacem: Writing – original draft. Jamel Ben Hassouna: Visualization, Investigation. Tarek Ben Dhiab: Visualization. ABBREVIATION LIST: Persistent Müllerian Duct Syndrome Computed Tomodensitometry Alpha fetoprotein Lactate Dehydrogenase Beta-Human Chorionic Gonadotropin Anti-Mullerian Hormone Anti-Mullerian Hormone Receptor Type 2 Magnetic Resonance Imaging References